Go to page content

Basal insulin products in MDI

The basal insulin used in MDI therapy is insulin degludec, insulin detemir or insulin glargine.

​​Insulin detemir

For insulin deficiency, insulin detemir is administered twice a day, in the morning and evening. It is particularly suitable for people in MDI therapy who need to repeatedly alter their insulin dose, for instance, because of long-lasting physical activity or exercise.

Insulin glargine

Normally, 100 units/ml insulin glargine can be administered once a day. However, for some people, the effect is more even and effective, especially on morning blood sugar, when the dose is divided into two injections.

Insulin glargine 300 units/ml is administered once a day at any time of the day but about the same time each day. Hypoglycaemia is less common for 300 units/ml insulin glargine products compared to 100 units/ml insulin glargine or insulin detemir.

Insulin Decludec

Insulin degludec 100 units/ml or 200 units/m is administered once a day. In terms of the time of injection, it is the most flexible of the basal insulin products. The time of injection can vary from day to day as long as the time between injections is at least 8 hours but no more than 40 hours. Therefore, it is especially suitable for persons whose daily routines vary, for example, due to occasionally sleeping in, shift work or frequently crossing time zones while travelling. Too low blood sugars are less common for insulin degludec compared to 100 units/ml insulin glargine or insulin detemir.

Updated 30.9.2023